VeraDermics Inc. Secures Licensing of First-in-Class Antiviral Targeting the Treatment of Molluscum Contagiosum and other Poxviruses
West Hartford, CT (PRWEB) August 23, 2022 -- VeraDermics Incorporated, developer of drugs for dermatology, today announced that it has entered into a
Source: prweb.com